Autobio Diagnostics Co., Ltd. (SHA:603658)

China flag China · Delayed Price · Currency is CNY
35.20
+0.28 (0.80%)
Mar 10, 2026, 11:29 AM CST
-16.07%
Market Cap 19.95B
Revenue (ttm) 4.22B
Net Income (ttm) 1.10B
Shares Out 571.42M
EPS (ttm) 1.92
PE Ratio 18.20
Forward PE 17.29
Dividend 1.26 (3.60%)
Ex-Dividend Date May 26, 2025
Volume 1,011,840
Average Volume 2,277,806
Open 35.10
Previous Close 34.92
Day's Range 35.08 - 35.39
52-Week Range 34.32 - 43.20
Beta 0.00
RSI 35.95
Earnings Date Apr 23, 2026

About Autobio Diagnostics

Autobio Diagnostics Co., Ltd. engages in the research and development, production, marketing, sale, and service of clinical diagnostic products in China and internationally. The company offers immunoassay, biochemistry, and microbiology products; reagents and instruments; and technical and support, and training services, as well as engages in biology research and development activities. Its immunoassay products consist of AutoLumo S900 and AutoLumo A1860 that provides user experience for small and medium size labs; AutoLumo A6200/A6600, an auto... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1998
Employees 5,773
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603658
Full Company Profile

Financial Performance

In 2024, Autobio Diagnostics's revenue was 4.47 billion, an increase of 0.62% compared to the previous year's 4.44 billion. Earnings were 1.19 billion, a decrease of -1.89%.

Financial Statements

News

There is no news available yet.